Parathyroidinum 8 X Drops ; Globules ; Granules ; Liquid ; Pellet ; Tablet is a Health Canada–registered human drug (DIN 02235032) held by Seroyal International Inc., containing Parathyroid Hormone. Health Canada lists its status as Cancelled Post Market (status date 23 Aug 2004). Nexara Health has matched 28 registrations of Parathyroid Hormone across 8 other regulated markets.
Health Canada registration
| DIN | 02235032 |
|---|---|
| Brand name | Parathyroidinum |
| Active ingredient | Parathyroid Hormone |
| Strength | 8 X |
| Dosage form | Drops ; Globules ; Granules ; Liquid ; Pellet ; Tablet |
| Route | Oral |
| Company | Seroyal International Inc. |
| Status | Cancelled Post Market — 23 Aug 2004 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Parathyroid Hormone registered in other markets
28 registrations of the same molecule in 8 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | 100 mikrogram | pulver og solvens til injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | 50 mikrogram | pulver og solvens til injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | 75 mikrogram | pulver og solvens til injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| Denmark | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | 25 mikrogram | pulver og solvens til injektionsvæske, opløsning | Central | Laegemiddelstyrelsen |
| European Union (EMA) | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | Withdrawn | EMA centrally authorised | ||
| European Union (EMA) | Preotact | NPS Pharma Holdings Limited | Withdrawn | EMA centrally authorised | ||
| Greece | NATPAR PS.INJ.SOL 25MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου) | Takeda Pharmaceuticals International AG Ireland Branch, Ireland | reimbursed | MoH deltio timwn | ||
| Greece | NATPAR PS.INJ.SOL 50MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου) | Takeda Pharmaceuticals International AG Ireland Branch, Ireland | reimbursed | MoH deltio timwn | ||
| Greece | NATPAR PS.INJ.SOL 75MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου) | Takeda Pharmaceuticals International AG Ireland Branch, Ireland | reimbursed | MoH deltio timwn | ||
| Ireland | Natpar 100 micrograms/dose powder and solvent for solution for injection | Shire Pharmaceuticals Ireland Limited | Powder and solvent for solution for injection | Unknown | HPRA | |
| Ireland | Natpar 25 micrograms/dose powder and solvent for solution for injection | Shire Pharmaceuticals Ireland Limited | Powder and solvent for solution for injection | Unknown | HPRA | |
| Ireland | Natpar 50 micrograms/dose powder and solvent for solution for injection | Shire Pharmaceuticals Ireland Limited | Powder and solvent for solution for injection | Unknown | HPRA | |
| Ireland | Natpar 75 micrograms/dose powder and solvent for solution for injection | Shire Pharmaceuticals Ireland Limited | Powder and solvent for solution for injection | Unknown | HPRA | |
| Netherlands | Natpar 100 microgram, poeder en oplosmiddel voor oplossing voor injectie in voorgevulde pen | Takeda Pharmaceuticals International AG Ireland Branch | Poeder en oplosmiddel voor oplossing voor injectie | Uitsluitend recept | EU national register | |
| Norway | Natpar pulv+væske til inj oppl 25 mikrog/dose | Takeda | 2 x 350 | Pulver og væske til injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Natpar pulv+væske til inj oppl 25 mikrog/dose | Takeda Pharmaceuticals International AG Ireland Branch | 2 x 350 | Pulver og væske til injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Natpar pulv+væske til inj oppl 50 mikrog/dose | Takeda | 2 x 700 | Pulver og væske til injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Natpar pulv+væske til inj oppl 50 mikrog/dose | Takeda Pharmaceuticals International AG Ireland Branch | 2 x 700 | Pulver og væske til injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Natpar pulv+væske til inj oppl 75 mikrog/dose | Takeda Pharmaceuticals International AG Ireland Branch | 2 x 1050 | Pulver og væske til injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Poland | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | 50 mcg/dawkę | Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań | URPL RPL | |
| Poland | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | 75 mcg/dawkę | Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań | URPL RPL | |
| Poland | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | 100 mcg/dawkę | Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań | URPL RPL | |
| Poland | Natpar | Takeda Pharmaceuticals International AG Ireland Branch | 25 mcg/dawkę | Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań | URPL RPL | |
| United Kingdom | Parathyroid hormone 1.61mg powder and solvent for solution for injection cartridges | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Parathyroid hormone 100micrograms/71.4microlitre dose powder and solvent for solution for injection cartridges | — | 0009 | NHS dm+d VMP | ||
| United Kingdom | Parathyroid hormone 25micrograms/71.4microlitre dose powder and solvent for solution for injection cartridges | — | 0009 | NHS dm+d VMP | ||
| United Kingdom | Parathyroid hormone 50micrograms/71.4microlitre dose powder and solvent for solution for injection cartridges | — | 0009 | NHS dm+d VMP | ||
| United Kingdom | Parathyroid hormone 75micrograms/71.4microlitre dose powder and solvent for solution for injection cartridges | — | 0009 | NHS dm+d VMP |
See every manufacturer of Parathyroid Hormone worldwide →
Regulator price references for Parathyroid Hormone
Published list or reimbursement prices for Parathyroid Hormone presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Greece | NATPAR PS.INJ.SOL 25MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου) | 0.025mg | 5,351.39 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | NATPAR PS.INJ.SOL 75MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου) | 0.075mg | 5,351.39 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | NATPAR PS.INJ.SOL 50MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου) | 0.05mg | 5,352.89 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Norway | Natpar | 1050 mikrog | 72,428.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Natpar | 700 mikrog | 72,428.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Natpar | 350 mikrog | 72,428.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Parathyroidinum (DIN 02235032) marketed in Canada?
No. Health Canada lists DIN 02235032 as Cancelled Post Market as of 23 Aug 2004.
Who holds the Canadian licence for this product?
Seroyal International Inc. is the company of record in the Health Canada Drug Product Database.
Is Parathyroid Hormone registered outside Canada?
Yes — Nexara Health has matched 28 registrations in 8 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02235032, status date 2004-08-23; national medicine registries: EMA centrally authorised, EU national register, FEST (DMP), HPRA, Laegemiddelstyrelsen, MoH deltio timwn, NHS dm+d VMP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, MoH deltio timwn. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02235032, status date 2004-08-23; national medicine registries: EMA centrally authorised, EU national register, FEST (DMP), HPRA, Laegemiddelstyrelsen, MoH deltio timwn, NHS dm+d VMP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, MoH deltio timwn.
Health Canada Drug Product Database (DPD), DIN 02235032, status date 2004-08-23; national medicine registries: EMA centrally authorised, EU national register, FEST (DMP), HPRA, Laegemiddelstyrelsen, MoH deltio timwn, NHS dm+d VMP, URPL RPL; price sources: DMP (Statens legemiddelverk) maksimalpris, MoH deltio timwn. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.